Search

Your search keyword '"CARMELO CARLO STELLA"' showing total 14 results
Start Over Author "CARMELO CARLO STELLA" Journal hematological oncology
14 results on '"CARMELO CARLO STELLA"'

1. GLOFITAMAB STEP‐UP DOSING: UPDATED EFFICACY DATA SHOW HIGH COMPLETE RESPONSE RATES IN HEAVILY PRETREATED RELAPSED/REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL) PATIENTS

Author

Gloria Iacoboni, Anna Sureda, F. Morschhauser, Kathryn Humphrey, Martin Hutchings, Emma Clark, Michael Crump, Michael Dickinson, Emily Piccione, Carmelo Carlo-Stella, Corinne Haioun, James Relf, Emmanuel Bachy, Anton Belousov, David Carlile, Fritz Offner, Linda Lundberg, and David Perez-Callejo

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, Hematology, General Medicine, Internal medicine, Relapsed refractory, Medicine, Hodgkin lymphoma, Dosing, business, Complete response
Published
2021
Full Text
View/download PDF

2. PHASE 3 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE PLUS RITUXIMAB VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA – LOTIS‐5

Author

M. Chung, Carmelo Carlo-Stella, Mitul Gandhi, Yuliya Linhares, Mehdi Hamadani, D. Ungar, and H. Adamis

Subjects
Cancer Research, medicine.medical_specialty, business.industry, Hematology, General Medicine, medicine.disease, Gastroenterology, law.invention, Oncology, Randomized controlled trial, law, Internal medicine, Relapsed refractory, medicine, Rituximab, In patient, business, Diffuse large B-cell lymphoma, medicine.drug
Published
2021
Full Text
View/download PDF

3. CAMIDANLUMAB TESIRINE EFFICACY AND SAFETY IN AN OPEN‐LABEL, MULTICENTER, PHASE 2 STUDY OF PATIENTS (PTS) WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL)

Author

Kerry J. Savage, Jens Wuerthner, Justin Kline, Mehdi Hamadani, P. L. Zinzani, L. Wang, Kami J. Maddocks, Graham P. Collins, S. M. Ansell, Carmelo Carlo-Stella, Paolo Caimi, Hans G Cruz, Y. Negievich, Nancy L. Bartlett, John Radford, and Alex F. Herrera

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, business.industry, medicine.medical_treatment, Phases of clinical research, Hematology, General Medicine, Immunotherapy, Refractory, Internal medicine, medicine, Classical Hodgkin lymphoma, Hodgkin lymphoma, Open label, business
Published
2021
Full Text
View/download PDF

4. LOTIS 2 FOLLOW‐UP ANALYSIS: UPDATED RESULTS FROM A PHASE 2 STUDY OF LONCASTUXIMAB TESIRINE IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

Author

Carmelo Carlo-Stella, Juan Pablo Alderuccio, Mehdi Hamadani, Brad S. Kahl, John Radford, Brian T. Hess, Yajuan Qin, Shui He, Anastasios Stathis, P. L. Zinzani, David Ungar, Jay Feingold, W. Y. Ai, Melhem Solh, Kirit M. Ardeshna, and Paolo Caimi

Subjects
Cancer Research, medicine.medical_specialty, Oncology, business.industry, medicine, Phases of clinical research, Refractory Diffuse Large B-Cell Lymphoma, Hematology, General Medicine, Radiology, business
Published
2021
Full Text
View/download PDF

5. A PHASE 2 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE (LONCA) VERSUS (VS) IDELALISIB IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL) – LOTIS‐6

Author

L. Wang, Carmelo Carlo-Stella, Brian T. Hess, P. L. Zinzani, D. Ungar, Kirit M. Ardeshna, V. Dai, J. Depaus, and E. Kingsley

Subjects
Cancer Research, medicine.medical_specialty, business.industry, Follicular lymphoma, Hematology, General Medicine, medicine.disease, Gastroenterology, law.invention, Oncology, Randomized controlled trial, Refractory, law, Internal medicine, medicine, In patient, Idelalisib, business
Published
2021
Full Text
View/download PDF

6. CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER IN CLASSIC HODGKIN LYMPHOMA

Author

Bernhard Gerber, Jan Maciej Zaucha, A. Stasia, E. Borsatti, Carmelo Carlo-Stella, Alessio Bruscaggin, Valeria Spina, Salvatore Annunziata, Anastasios Stathis, M. Kurlapski, F. Cavalli, Alden A. Moccia, Luca Ceriani, Gabriela Forestieri, G. Romanowicz, D. Rossi, Antonello Pinto, Ricardo Koch, Gian Mauro Sacchetti, Gianluca Gaidano, Georg Stussi, Adalgisa Condoluci, Riccardo Moia, S. Chauvie, M. Faderl, Maria Cristina Pirosa, I. Zangrilli, S. Hohaus, K. Pini, S. Gillessen Sommer, M. G. Cittone, Pietro Bulian, M. di Trani, Emanuele Zucca, Marcello Rodari, D. Piffaretti, L. Terzi di Bergamo, and V. Gattei

Subjects
Cancer Research, Oncology, Circulating tumor DNA, business.industry, Cancer research, Hodgkin lymphoma, Medicine, Prognostic biomarker, Hematology, General Medicine, business
Published
2021
Full Text
View/download PDF

7. CLINICAL ACTIVITY OF LONCASTUXIMAB TESIRINE PLUS IBRUTINIB IN NON‐HODGKIN LYMPHOMA: UPDATED LOTIS 3 PHASE 1 RESULTS

Author

S. De Guibert, Tycel Phillips, Xiaomin He, Murali Janakiram, Julien Depaus, Silvia Ferrari, Carmelo Carlo-Stella, Joseph Boni, Locke J. Bryan, Karin Havenith, Monica Tani, Annette Ervin-Haynes, Emmanuel Bachy, P. L. Zinzani, Nina Wagner-Johnston, Joseph Maly, Vivian Dai, and Vincent Delwail

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, Hematology, General Medicine, chemistry.chemical_compound, chemistry, Internal medicine, Phase (matter), Ibrutinib, medicine, Hodgkin lymphoma, business
Published
2021
Full Text
View/download PDF

8. ANALYSIS OF EFFICACY AND SAFETY OF LONCASTUXIMAB TESIRINE (ADCT-402) BY DEMOGRAPHIC AND CLINICAL CHARACTERISTICS IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

Author

S. He, John Radford, Leonard T. Heffner, Owen A. O'Connor, Jay Feingold, Mehdi Hamadani, Brad S. Kahl, D. Ungar, Melhem Solh, Carmelo Carlo-Stella, Erin Reid, Ki-Young Chung, Kirit M. Ardeshna, and Paolo Caimi

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, Internal medicine, Relapsed refractory, Medicine, Hematology, General Medicine, business, medicine.disease, Diffuse large B-cell lymphoma
Published
2019
Full Text
View/download PDF

9. DOSE DENSE ABVD (DD-ABVD) AS FIRST LINE THERAPY IN EARLY-STAGE UNFAVORABLE HODGKIN LYMPHOMA (HD): RESULTS OF A PHASE II, PROSPECTIVE STUDY BY FONDAZIONE ITALIANA LINFOMI

Author

Alessandro Pulsoni, Maurizio Musso, Francesco Merli, Umberto Ricardi, F. Palombi, R. Mazza, Michele Spina, Armando Santoro, S. Chauvie, Monica Balzarotti, U. Consoli, S. Kovalchuk, Angelo Fabbri, Andrea Gallamini, F. Ricci, Carmelo Carlo-Stella, M. Carella, Angelo Liberati, Francesco Gaudio, Maurizio Bonfichi, Catello Califano, M. Rodari, and Laura Giordano

Subjects
Oncology, Cancer Research, Chemotherapy, medicine.medical_specialty, business.industry, medicine.medical_treatment, Hematology, General Medicine, Unfavorable Hodgkin Lymphoma, First line therapy, ABVD, Internal medicine, medicine, Stage (cooking), business, Prospective cohort study, medicine.drug
Published
2019
Full Text
View/download PDF

10. IMPACT OF CLASS II HLA MISMATCH ON CLINICAL OUTCOMES IN HODGKIN LYMPHOMA PATIENTS RECEIVING HAPLOIDENTICAL STEM CELL TRANSPLANTATION (HAPLO-SCT) WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE (PT-CY)

Author

R. Bouabdallah, Thomas Pagliardini, Raynier Devillier, Samia Harbi, Christian Chabannon, Faezeh Legrand, Sabine Furst, Jacopo Mariotti, L. Castagna, Stefania Bramanti, A Granata, Claude Lemarie, Valerio Maisano, Antonella Santoro, Didier Blaise, Boris Calmels, C. De Philippis, Barbara Sarina, and Carmelo Carlo-Stella

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Post transplant cyclophosphamide, business.industry, Hematology, General Medicine, HLA Mismatch, Transplantation, Internal medicine, Medicine, Hodgkin lymphoma, Stem cell, business
Published
2019
Full Text
View/download PDF

11. CD20-TCB (RG6026), A NOVEL '2:1' FORMAT T-CELL-ENGAGING BISPECIFIC ANTIBODY, INDUCES COMPLETE REMISSIONS IN RELAPSED/REFRACTORY B-CELL NON-HODGKIN'S LYMPHOMA

Author

Pablo Umana, Ann-Marie Broeske, Franck Morschhauser, Natalie Dimier, Peter N. Morcos, Fritz Offner, Denise Thomas, Carmelo Carlo-Stella, Michael Dickinson, Gilles Salles, Tom Moore, Michael Crump, J. Martinez, Martin Weisser, Cristiano Ferlini, Martin Hutchings, Marina Bacac, Gloria Iacoboni, and Anna Sureda

Subjects
CD20, Cancer Research, Bispecific antibody, biology, business.industry, T cell, Hematology, General Medicine, medicine.disease, Non-Hodgkin's lymphoma, medicine.anatomical_structure, Oncology, Relapsed refractory, medicine, Cancer research, biology.protein, business, B cell
Published
2019
Full Text
View/download PDF

12. MANTLE CELL LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE: A RETROSPECTIVE MULTICENTER OBSERVATIONAL STUDY OF THE EUROPEAN MANTLE CELL LYMPHOMA NETWORK

Author

Sara Rattotti, Simone Ferrero, A. Di Rocco, Michal Szymczyk, Martin Dreyling, Giuseppe Carli, Filipa Moita, Antonella Santoro, Laura Giordano, Luca Arcaini, Lucia Morello, Igor Aurer, T. van Meerten, Katarzyna Krawczyk, Mats Jerkeman, Carmelo Carlo-Stella, T.C. El-Galaly, Dario Marino, and Irene Defrancesco

Subjects
Cancer Research, Pathology, medicine.medical_specialty, Oncology, business.industry, medicine, Observational study, Mantle cell lymphoma, Hematology, General Medicine, medicine.disease, business, Mucosa-associated lymphoid tissue
Published
2017
Full Text
View/download PDF

13. Genotyping of Classical Hodgkin Lymphoma on the Liquid Biopsy

Author

Valeria Spina, Fary Diop, Stefan Hohaus, Carmelo Carlo-Stella, Adalgisa Condoluci, Luigi Maria Larocca, Maurizio Martini, Davide Rossi, Anastasios Stathis, Franco Cavalli, Alden A. Moccia, Elisa Cupelli, Gabriela Forestieri, Gianluca Gaidano, Alessio Bruscaggin, Martina Manzoni, Georg Stussi, Clara Deambrogi, Francesco Bertoni, Annarosa Cuccaro, M. di Trani, Emanuele Zucca, and Silvia L. Locatelli

Subjects
Cancer Research, Pathology, medicine.medical_specialty, business.industry, Hematology, General Medicine, 03 medical and health sciences, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Classical Hodgkin lymphoma, Medicine, Liquid biopsy, business, Genotyping, 030215 immunology
Published
2017
Full Text
View/download PDF

14. SAFETY AND CLINICAL ACTIVITY OF RP6530, A DUAL PI3Kδ/γ INHIBITOR, IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES: FINAL ANALYSIS OF A PHASE 1 MULTI-CENTER STUDY

Author

P. Barde, Lydia Scarfò, S. Viswanadha, Sara Gandolfi, Massimo Magagnoli, Richard Delarue, Carmelo Carlo-Stella, Enrico Lugli, V. Pittari, Lucia Morello, Silvia L. Locatelli, Anna Ferreri, Antonella Santoro, F. De Paoli, and Karolina Pilipow

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, Phase (waves), Hematology, General Medicine, DUAL (cognitive architecture), 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Multi center study, medicine, In patient, business, Intensive care medicine, 030215 immunology
Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results